Podcasts about healthtech

It's in our water, our food, and so many other products we use on a daily basis, from non-stick pans to popcorn bags. And it's making us really sick.More and more scientists are becoming concerned that PFAS chemicals, also known as “forever chemicals,” are impacting human health. Evidence is growing that links these everyday exposures, particularly to endocrine-disrupting chemicals (or EDCs), are linked to cancer, infertility, birth defects, asthma, allergies, cardiovascular disease, diabetes, obesity, and more.In this episode, we talk to one of the world's leading environmental health scientists and advocates about the impact of forever chemicals and what we can do about it. Arlene Blum is the founder and executive director of the Green Science Policy Institute. This is a replay from 2022.We cover:

How does a healthcare startup reach 200,000 users across 44 countries without spending a dollar on marketing? Our latest episode reveals the power of clinical expertise over marketing budgets.

In this episode of Medsider Radio, we sat down with Juan C. Jimenez, co-founder and CEO of AccurKardia, a startup developing software that uses ECG data to help doctors detect heart conditions more accurately and efficiently with AI. Juan started his career as an investment banker specializing in M&A transactions, then moved on to become President of Puerto Rico's largest non-emergency medical transportation company, TransCita. Now, he's making waves in the ECG diagnostics space with AccurKardia. Leveraging his background in finance and healthcare, Juan brings unique expertise on efficiency and scale for medtech startups.In this interview, Juan talks about how to scale sustainably with optimal dilution, giving your team space to establish a solid product, forging authentic relationships with potential customers, and leveraging your credibility to move your business forward.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Juan C. Jimenez.

In this episode, listeners get a chance to revisit an episode from last year with Ayse McCracken, the founder of Ignite Healthcare Network, an organization that accelerates female-founded businesses within health care. In November, Ignite hosted its annual Fire Pitch Competition, the main event for its accelerator that supports and connects female health tech founders with the Texas Medical Center's vast network of experts and health care organizations. At the event, the founders pitched their health tech solutions across lung health, renal therapy, breastfeeding tech, and more. This year's first place winner was Sarah Lee, CEO and co-founder of Relavo, a New York-based company that's making home dialysis more effective, safer, and more affordable. Link to read about the 2024 Fire Pitch Competition winners: https://houston.innovationmap.com/ignite-health-relavo-fire-pitch-2670292174.html

Episode 43 - Dr. Sara Kayat, resident GP on ITV's This Morning, authored How to Have a Baby, an empowering guide to pregnancy, birth, breastfeeding, and your baby's first year. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Andrew Lacy stumbled into entrepreneurship after failing to land a tech job. His first company did so well that he eventually sold it to Disney. Believing he had business all figured out, he launched another company, only to realize that success wasn't guaranteed. For his next venture, Prenuvo, Andrew took a more thoughtful approach, but investors repeatedly rejected the idea. Determined to make it work, he bootstrapped and secured loans to launch a clinic in Silicon Valley. Today, Prenuvo is revolutionizing preventive healthcare. In this episode, Andrew shares valuable insights on reinventing yourself, making bold career changes, and pushing through setbacks to bring innovative ideas to life. Andrew Lacy is an Australian serial entrepreneur, angel investor, and the founder/CEO of Prenuvo, a pioneering health tech company using whole-body imaging for early disease detection, including cancer. In this episode, Ilana and Andrew will discuss: (00:00) Introduction  (00:35) From Lawyer to Accidental Tech Entrepreneur (06:44) Lessons from His First Business (13:19) The Pains and Gains of Having a Co-founder (14:59) Starting a Company, Again? (17:24) Cultural Differences in Entrepreneurship (19:57) Tough Truths About Building a Startup (22:44) The Health Scan That Birthed Prenuvo (28:33) Dealing with Investor Rejection (35:11) The Future of Healthcare with Prenuvo (36:35) A Surprising Fact About Andrew (37:56) His Hack for Aspiring Entrepreneurs Andrew Lacy is an Australian serial entrepreneur, angel investor, and founder/CEO of Prenuvo, a pioneering health tech company using whole-body imaging for early disease detection, including cancer. He envisions a future where healthcare is more affordable and accessible, and where people embrace health screenings as tools for long-term wellness. Andrew also co-founded Tapulous, a key player in the early iPhone app ecosystem, later acquired by Disney. He has held leadership roles at McKinsey and Disney. Connect with Andrew: Andrew's Website: https://andrewlacy.com/ Andrew's LinkedIn: https://www.linkedin.com/in/andrewllacy/  Leap Academy: Ready to make the LEAP in your career? There is a NEW way for professionals to Advance Their Careers & Make 5-6 figures of EXTRA INCOME in Record Time. Check out our free training today at leapacademy.com/training

Tune in to learn how Natalie Davis and her organization, United States of Care, listens to diverse communities across America to identify shared healthcare values and translate those insights into impactful policy recommendations.  They work to identify themes of putting patients first, addressing the challenges of achieving affordable healthcare, reframing the value-based care conversation, and addressing the role of AI in healthcare, all while working to advocate everyone has access to quality, affordable care.  Natalie shares her unique journey from museum curator to healthcare advocate, discussing her experiences at CMS during the Affordable Care Act rollout and her passion for data-driven change. 

What's the boldest company in healthcare? In our last Digital Health Download of the year, Halle and Steve stumble over the answer to this question and break down the latest healthcare headlines and what they mean for our sector.We cover:

BioCertica is Africa's first digital biobank, combining advanced genetic testing and encryption technology to empower individuals with secure, actionable genetic insights. Pioneers in polygenic risk scoring for direct-to-consumer testing. Arno is the Co-founder and Chief Product Officer with expertise in product management, marketplaces, and HealthTech innovation. Jamie is a Business Development Manager and MSc candidate in functional genetics, driving BioCertica's local and global growth.

Welcome to a new episode of the EUVC podcast, where our good friends Dan Bowyer and Mads Jensen from SuperSeed, discuss with Lomax Ward, General Partner at Outsized Ventures, to cover recent news and movements in the European tech landscape

James, Jessica and Belle from SomX break down the best stories from this week's newsletter. [14:20] - AI tool could predict type 2 diabetes 10 years in advance[40:50] - Many digital health startups are quietly raising down rounds and closing up shop. Here's why

Strategic education choices can help you break through career ceilings and thrive in health tech. _______________________  Follow Medical Sales U:  https://medicalsalesu.com/ https://www.facebook.com/MedicalSalesU1 https://www.instagram.com/medicalsalesu https://www.linkedin.com/company/medical-sales-u

Giovanna Carucci Ceo&Founder #Authenticleader Generative Coach certificata dalla IAGC di Robert Dilts e Stephen Gilligan, NLP Advanced Master Practitioner in Business e Life Coaching presso l'istituto NLP ITALY®, certificato dalla NLP Society® di Richard Bandler, Practitioner in Creative Mind e Generative Trance di Stephen Gilligan in Italia. Laureata in Bocconi, dopo decenni come manager nel mondo della moda e del lusso, decide di dedicarsi anima e corpo al coaching, che svolge con grande passione e particolare attenzione allo sviluppo delle potenzialità, al business coaching e alla leadership. Docente in Conscious leadership presso Polimi Graduate School of Management. Contributor per diverse testate nazionali ed internazionali su temi di leadership e imprenditorialità. Il corso di formazione Purpose e Leadership Consapevole di POLIMI Graduate School of Management, la business school del Politecnico di Milano, rappresenta un'opportunità unica per esplorare e sviluppare le competenze necessarie per guidare con efficacia, ispirando gli altri e promuovendo una cultura organizzativa orientata a uno scopo superiore (higher purpose), valori autentici e consapevolezza. Durante il corso, si approfondisce l'importanza dell'autenticità personale, di una visione chiara e di un impegno condiviso verso un purpose comune. Il corso Purpose e Leadership Consapevole si inserisce nella strategia di formazione di POLIMI Graduate School of Management: attraverso le sue attività formative e di disseminazione, la Scuola ambisce a diventare il punto di riferimento per imprese e manager che intendono investire in modelli di business sostenibili guidati dal purpose. Il corso si articola in due giorni con due sessioni da otto ore e viene erogato in modalità blended (online e presso il Campus Bovisa di Milano). Purpose e Leadership Consapevole è un modulo formativo realizzato da POLIMI Graduate School of Management in partnership con Authenticleader, società di consulenza e formazione per trasformare le imprese in luoghi di crescita per le persone, introducendo un nuovo modo di fare business più consapevole e orientato alla sostenibilità umana, ambientale e di sistema. POLIMI Graduate School of Management è la business school del Politecnico di Milano, dove ogni giorno vengono ispirati i business leader di domani e le aziende in cui lavorano, nella consapevolezza di poter giocare un ruolo cruciale per creare un futuro migliore per tutti. Nata oltre 40 anni fa a Milano come MIP Politecnico di Milano, POLIMI GSoM è oggi una Società benefit, composta dall'Ateneo e da un gruppo di aziende leader, italiane e internazionali. Offre più di 40 master, tra cui anche MBA ed Executive MBA, un catalogo di oltre 300 programmi open, e percorsi formativi su misura per le aziende. Come parte della School of Management, è tra le poche scuole nel mondo (

Prof Blackford Middleton joins us in the PulsePod studio to discuss his philosophising on the intersection of AI and healthcare, and his new publication The Ouroboros Effect: How AI Threatens Human Intellect. LinkIn this episode of Pulse, Louise and George explore the hottest topics in digital health, from groundbreaking AI diagnosis studies to the collapse of a high-profile health startup, and news from UK, AU and NZ. Here's what we cover:Professional Identity: When Machines Outperform DoctorsWe revisit a JAMA study showing ChatGPT outperformed doctors in diagnosis, even when clinicians had access to the tool. The debate heats up as commentary pours in, questioning professional identity, training gaps, and the cultural impact on medicine. Link‘Doc in a Box' Fails: Lessons from Forward Health's CollapseForward Health, a $650M-backed US health startup, closed abruptly, leaving patients and employees in limbo. We discuss the pitfalls of tech-first healthcare models, investor errors, the importance of clinician and patient advisory roles, and the future of primary care.NZ Sets a Goal for Digital CareNew Zealand aims for 10% of care delivered digitally by mid-2025. The timing is ambitious, but is the target?Health Data as National Infrastructure: The UK's VisionA new report calls for treating health data as critical national infrastructure. We delve into its recommendations for a national health data strategy, governance, and patient benefit, reflecting on global implications for health data ecosystems. LinkShareByDefault: Australia's Health Data RevolutionAustralia's Health Minister introduces a bill mandating the sharing of pathology results and imaging through MyHealthRecord. What does this mean for patients and clinicians?Finally: Independent Evaluation of Generative AIIn the US the Healthcare AI Challenge Collaborative has been established to comparing the efficacy of generative AI tools for healthcare. They will produce public rankings of 9 commercial tools before Xmas. Follow Blackford Middleton on LinkedInVisit Pulse+IT.news to learn more, engage in this rapidly growing sector, and subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

The James Dyson Award has long championed innovative solutions that address real-world challenges, from everyday inconveniences to critical health issues. One such solution is a groundbreaking tool developed to reduce discomfort during mammograms. This unique invention, recognized as the national winner of the award, showcases how design-driven innovation can make a tangible difference in healthcare. How can this award inspire more breakthroughs that improve patient care and encourage proactive health practices? Here's our conversation with Brian Hu, Head of Electronics, Dyson (and judge for the 2024 James Dyson Award) &  Luke Goh, Industrial Design Graduate, NUS (and inventor of Mammosense).   Presented by Emaad Akhtar This podcast is produced and edited by Anthea Ng (nganthea@sph.com.sg) She produces Mind Your Business, Biz-How-To and Breakfast Special segments on the Breakfast Show. Do contact her for topics: C-Suite, SME, Startups, Health-tech, Sustainability, Property, Intergenerational Family Business, Industry Outlook, Fintech and trending businesses in town.      See omnystudio.com/listener for privacy information.

“If you're not learning something new every day, even if it's the smallest thing, you can start to almost become stationary. Find ways to push yourself out of the limits of what you feel comfortable with.”  In today's 40 Minute Mentor episode, we're joined by Dr Dupe Burgess, Founder & CEO of Bloomful.  Launched in 2021, Bloomful is a HealthTech on a mission to close the gender health gap and improve access to gynae care for women, globally.  Dupe and her team have been on an incredibly successful journey so far, having reached over 4,000 women with their first triage tool in just a few weeks and receiving equity-free funding from both, Google and KPMG.  With a background in medicine, working at some of the busiest NHS hospitals in the UK and strategy consulting at BCG, Dupe brings a wealth of first-hand knowledge and experience to tackle the problem Bloomful is solving today.  Find out more in today's episode…  Episode Chapters: ➡️ Upbringing and landing in a medical career [04:15]  ➡️ Spending eight years in the NHS [08:15]  ➡️ Transitioning from being a Doctor to a Big 4 strategy consultant [12:15]  ➡️ Bloomful's origin story [18:20]   ➡️ More about Leadership Unleashed [21:30]  ➡️ Closing the gender health gap [23:00]  ➡️ Securing investment early on [28:00]  ➡️ The importance of storytelling in fundraising [31:15]  ➡️ Hiring for the sake of hiring & other lessons learned [33:50]  ➡️ Advice for growing your personal brand on LinkedIn [38:00]  ⛳ Helpful links: ➡️ Connect with Dupe: https://www.linkedin.com/in/dupeburgess/  ➡️ Find out more about Bloomful: https://www.bloomful.io/ 

Episode 42 - Dr. Hazel Wallace is a former NHS doctor, registered nutritionist, personal trainer, author, and founder of The Food Medic, a platform dedicated to providing practical, evidence-based nutrition and health advice. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

In this episode of Medsider Radio, we sat down with Dhruv Agrawal, CEO of Aether Biomedical. Aether's ZEUS bionic arm is a highly durable, multi-articulating prosthetic designed to handle everyday tasks with improved grip strength and resilience.Dhruv found his true calling in building prosthetics while he was studying medicine and proceeded to co-found Aether when he was 18. Since starting Aether, he has helped raise over $15 million in funding and guided the launch of the ZEUS bionic hand, now deployed worldwide, including those impacted by the war in Ukraine.In this interview, Dhruv discusses the importance of defining a clear problem statement, his approach to using grants to supplement VC funding, and the lessons he's learned about evaluating market opportunities while operating globally.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Dhruv Agrawal.

This week on found, Dom and Becca are talking with the co-founders of Alloy Women's Health who just closed a new funding round to expand its mission of fixing menopause care. Monica Molinar and Anne Fulenwider discuss raising capital in a competitive health tech landscape, their choice to bypass traditional insurance models, and how this funding will help them scale their telehealth platform nationally.00:00 - Introduction 04:37 - Turning personal experience into a business idea08:55 - The challenges of raising awareness about menopause10:00 - Why Alloy bypasses insurance 15:00 - Scaling a telehealth model18:06 - How the political landscape affects women's health20:00 - Addressing disparities in menopause treatment23:26 - Lessons from Alloy's fundraising journey30:00 - The benefits of a co-CEO leadership model37:17 - Closing thoughts Found posts every Tuesday. Subscribe on Apple, Spotify or wherever you listen to podcasts to be alerted when new episodes drop. Check out the other TechCrunch podcast: Equity . Subscribe to Found to hear more stories from founders each Connect with us:On TwitterOn InstagramVia email: found@techcrunch.com

Technology is transforming genetic testing and bringing hope to families facing rare diseases. In this episode, GeneDx (Nasdaq: WGS) CEO Katherine Stuhlin sits down with Steve Kraus to share how AI is being used to crack life's most complex code and speed up diagnosis from years to days.We cover:

When entrepreneurship and patient care meet, startups are driving innovation, spreading new models of care, and offering creative solutions to shared challenges. Join us to hone your entrepreneurial skills, learn from two leading innovaors - and spark your next great idea. Guests: Chenny Xia, CEO, Gotcare Rick Menassa, CEO, iCare Home Health and Health Espresso Learn More: Gotcare iCare Home Health Health Espresso Music:  RetroFuture Clean and Breakdown, by Kevin MacLeod. Used under Creative Commons. Summary: 00:52 Meet the Innovators: Chenny Xia and Rick Menassa 01:32 Journey to Entrepreneurship in Healthcare 03:01 Innovative Approaches in Home Care 08:00 Defining and Evolving Startups 14:36 Building Trust and Relationships 25:10 Advice for Aspiring Entrepreneurs 29:42 Reflections and Takeaways

In today's episode I speak with Graham Walker, MD, the co-founder of MDCalc.  In this conversation we talk about leadership, HealthTech and Graham's visionary HealthTech innovations including  MDCalc, the NNT, the Physicians' Charter for Responsible AI, and OffCall.  Graham is an emergency medicine physician in San Francisco and holds leadership positions with The Permanente Medical Group. He is trained in medical simulation and focuses on clinical informatics and AI in medicine. Graham created, edited, and co-authored the Physicians' Charter for Responsible AI, a practical guide for how AI should be adopted in medical care.  If you enjoy the show, please leave a ⭐⭐⭐⭐⭐ rating or review on Apple or YouTube and subscribe via the Website.

Bongani Bingwa speaks with Executive Strategic Growth at Altron Health Tech, Nicolette Mudaly, about their collaboration with Dis-Chem Oncology to alleviate the overwhelming complexities cancer patients face while navigating multiple care providers and complex treatment plans, through a developed technology solution that reduces the administrative burden on both patients and healthcare professionals, empowering them to focus on their health and recovery rather than the administrative complications.See omnystudio.com/listener for privacy information.

Episode 41 - Andrea Berchowitz is CEO and Co-Founder of Vira Health, a tech company on a mission to extend healthy life expectancy in women. Their first focus is menopause. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Despite heart disease being the leading cause of death in the United States, cardiovascular care has been an overlooked opportunity in digital health. With 1 in 3 Americans facing cardiovascular disease in their lifetime, how can innovation help turn the tide?In this episode, we explore heart health in the digital age with Dr. Jeff Wessler, cardiologist and founder/CEO of Heartbeat Health, the nation's largest virtual-first cardiovascular company.We cover:⌚If we can trust cardiovascular data from wearable devices (and what doctors call “Apple Heart Syndrome”)

Subscriber-only episodeIn this episode, we're diving into the intersection of technology and healthcare, specifically the role of Artificial Intelligence (AI) in clinical trials. As a Food and Drug lawyer, Darshan has seen firsthand how AI is revolutionizing drug development and testing. The FDA is closely monitoring this shift, recognizing the potential of AI to enhance patient outcomes, improve trial efficiency, and reduce costs.However, it's not all smooth sailing. AI can help identify the right patients for specific treatments, but it's crucial to address potential biases in AI algorithms, which could affect diversity in clinical trials. AI can also streamline trial processes, but the “black box” nature of how decisions are made raises concerns about transparency and fairness. Cost reduction is often touted, yet we're still waiting to see if AI will truly lower expenses in the long run.Data privacy and security are also big considerations. With AI relying on massive data sets, how can we ensure patient privacy is protected? And who truly owns the data? Algorithmic bias is another serious concern—especially when it comes to underrepresented patient populations. The FDA is working on issuing guidance for AI in clinical trials, but we're still in the early stages. They are encouraging collaboration between industry, academia, and other stakeholders to develop best practices. Plus, the FDA is investing in research to better understand both the benefits and risks of AI in healthcare.In the end, AI's potential is enormous, but we need to be careful about how it's implemented. What do you think are the biggest challenges when using AI in clinical trials? Drop your thoughts in the comments!And if you're a drug or medical device company looking to leverage AI, reach out to us at Kulkarni Law Firm for legal guidance through the complex regulatory landscape. Visit our website for more info.

The European Investment Fund (EIF) is committing a total of €90 million to three funds that incorporate Portuguese venture capital to accelerate the growth of start-up companies primarily in the country's deep tech and cybersecurity sector in Europe. The EIF pledges, announced at this year's Web Summit in Lisbon, will enable the three funds - Armilar Venture Partners IV, Faber Tech III and 33N Cybersecurity and Infrastructure Software Fund - to leverage more than €400 million of capital for tech start-ups, with operations already underway. The new financing highlights international confidence in Portugal as a technology hub while demonstrating the critical role of the EIF in promoting strategic investments in the technology sector in Europe. "We are very pleased with this achievement to boost Portugal entrepreneurship, venture capital and venture capital sectors. I strongly believe that start-ups and scale-ups will be critical for the digital and green transitions, driving the innovation that is indispensable to achieve them and, ultimately, our goals for sustainable economic growth. Our venture capital funds have a key role to play thanks to their ability to finance disruptive innovation," said the Portugal Minister for the Economy, Pedro Reis. "We are excited to support the next generation of innovation through these venture capital funds, which play an essential role in accelerating the growth of tech start-ups and in bolstering digital security in Europe," said EIF Chief Executive Marjut Falkstedt. "Our collaboration with local and international partners underlines our commitment to creating a robust and resilient ecosystem in the field of technology." The commitments by the EIF, which is part of the European Investment Bank (EIB) Group, are backed by the InvestEU programme aiming to mobilise over €372 billion in additional investments between 2021 and 2027. The 33N Cybersecurity and Infrastructure Software Fund, which specialises in cybersecurity and infrastructure software, has already held its first closings, having conducted 4 investments while continuing to raise up to €150 million. The team, with over 10 years of experience, has invested in more than 20 start-ups and has a solid track record of exits, with investors selling their stakes in the start-ups, and three unicorns. Its strategic focus is on cybersecurity companies in the global growth stage, including the European markets, UK, Israeli and US. Part of the investment in this fund is supported by the Luxembourg Future Fund 2 (LFF 2), developed in collaboration with the Société Nationale de Crédit et d'Investissement (SNCI). Faber is a team specialised in early-stage investment in science-based companies, having invested in over 50 deep tech start-ups, including one unicorn. The new fund, Faber Tech III, aims to support the first stages of start-ups in applied science fields such as AI for specific industries, robotics, computational biochemistry, data infrastructure, and new computing technologies. The fund will focus on the Iberian Peninsula and Southern Europe, with selective investments across the rest of Europe and occasionally beyond. With 25 years of experience and a track record of investing in more than 80 start-ups, including some of Portugal's unicorns, Armilar Venture Partners is one of Portugal's most established venture capital funds. The new fund, Armilar Venture Partners IV, aims to mobilise between €120 million and €250 million, supported by institutional investors, including the EIF. The fund's strategy is to focus on start-ups with strong technological differentiation in areas from computing to AI, HealthTech to SpaceTech, cybersecurity to productivity, with a primary focus on Portugal and Spain, as well as across Europe. The EIF is part of the European Investment Bank Group. Its core mission is to support micro, small and medium-sized enterprises in Europe by helping them access finance. The EIF designs and develops venture capital, guaran...

Welcome to the ThinkData podcast, in partnership with Dataworks!On today's episode, I'm joined by Jason Abrams.Jason is the VP of Revenue Strategy at Plenful, a Series A SaaS and AI startup in the digital health space. With over 15 years of sales experience, he's successfully led and grown teams at LinkedIn, Lyra Health, Color, and Spring Health.In this episode, we'll dive into building and scaling Sales and GTM teams within a startup.We covered a lot of ground:Jason's background and what brought him to PlenfulWho is Plenful and what problem is it looking to solveJason's thoughts on the Healthtech marketWhat are the most important factors and considerations companies should consider when building their ARR?What impact has AI and associated software had on sales teamsWhat makes a great sales leaderJason's advice to candidates who may be looking at sales as a career path

Elon Musk's Grok and Crowdsourcing Medical Data – Elon Musk invites the public to submit medical images to his AI, Grok, raising serious privacy concerns and questions about AI's role in medical diagnostics.Australia's Workforce Report on Healthcare Professionals – Louise and George discuss whether the Australian government's workforce report is reductive in its vision for the role of tech.Health Technology in Conflict Zones – Health technology innovations are transforming care in war zones, with tools like telemedicine and AI bridging gaps in access and resources for conflict-affected populations.The First Wearable to Kill Cancer Cells – A new FDA-approved wearable device uses electric fields to target and kill cancer cells without harming healthy cells, marking a significant step forward in digital cancer treatments.The results of the US election are in. What might be the impact on global health and digital innovation in health?Remote monitoring in the islands off Ireland gives Kate a trip down memory lane.World-Class Health Information Exchange – We welcome Dr. Robin Mann and Dr. Honor Magon, co-authors of a popular Pulse+IT opinion piece, to discuss the vision for a world-class Health Information Exchange and its potential impact.Visit Pulse+IT.news to learn more, engage in this rapidly growing sector, and subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on X Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Are your healthcare tech teams working overtime but missing growth targets? You're not alone. Many founders struggle to translate team effort into measurable success.

In this episode of Medsider Radio, we sat down with Steffen Hovard, CEO of Neuspera Medical, where his team is developing a novel, less invasive device that uses neuromodulation to treat conditions like overactive bladder.Previously, Steffen spent two decades at Coloplast, where he held various senior leadership roles that contributed to the company's growth, including the acquisition of a Minneapolis-based urology business in 2005. With deep expertise in the space, he has consistently driven growth and innovation across multiple functions, positioning himself as a leader of leaders in medtech, with board roles at Medical Alley and AdvaMed.In this interview, Steffen talks about confirming market fit before investing, building an early network for key hires and investors, aligning development speed with each phase, engaging with regulators early, and taking a steady, relationship-driven approach to fundraising.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Steffen Hovard.

In this episode, we sit down with Zillah Waminaje, a health technology expert, to discuss her journey in the health tech sector, the integration of technology with healthcare, and the innovations transforming health product access in Africa. Zillah shares insights on the challenges and opportunities within the health tech landscape, emphasizing the importance of partnerships and regulatory frameworks in driving impactful solutions. You can reach Zillah and Salient Advisory at: https://www.linkedin.com/in/zillahywaminaje/ https://x.com/salientadvisory/ https://www.salientadvisory.com/ Follow us: X (Twitter): https://x.com/insidethetechos/ Instagram: https://www.instagram.com/insidethetechos You can subscribe to our newsletter at https://insidethetechosystem.kit.com/ Show Notes & Resources (00:00) - Introduction to Health Tech and Its Integration with Healthcare (02:58) - Zila Waminage: A Journey in Health Technology (05:54) - Impactful Health Initiatives During COVID-19 (09:07) - Understanding Health Tech Innovations (11:58) - The Interconnectedness of Health Tech and Healthcare (14:48) - Challenges and Opportunities in Health Tech (18:02) - Salient Advisory: Bridging Innovators and Governments (26:32) - Overview of Health Product Access in Africa (30:17) - Innovators in Health Supply Chain (36:41) - Government Partnerships and Bureaucracy (43:32) - Financial Sustainability for Health Startups (46:49) - Future of Health Tech Innovations

Episode 40 - Amber Vodegel is a digital healthtech entrepreneur, with expertise in scaling health apps using AI and deep analytics, with a proven track record of building impactful digital health solutions. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Join Accenture's Ajay Mody and Asher Perzigian as we talk with Mike Niffenegger, SVP and General Manager of Harmony Cares, a leading provider of in-home primary care. Mike shares how Harmony Cares is revolutionizing healthcare delivery for complex patients, leveraging technology and a value-based approach to improve outcomes and patient satisfaction. He discusses the challenges and opportunities of in-home care and the future of this rapidly growing field. Tune in to learn how Harmony Cares is making a real difference in the lives of patients who need it most.

HLTH brings together all the ecosystem stakeholders each year to discuss the innovations that will help solve some of healthcare's biggest challenges. In this podcast episode, Noe Gutierrez, the Head of Commercial Operations at Genoplex, Inc., shares many of the key themes and insights from the biggest health tech conference of 2024.

Make America Healthy Again?It's official— Trump was elected as our 47th president and plans to use his second term to "go wild on health." For this special episode, Aneesh Chopra, former U.S. Chief Technology Officer and author of Innovative State: How New Technologies can Transform Government, joins Steve to talk about what we can expect in Trump's second term.We cover:

This LIVE interview took place with Eirini Schlosser in Las Vegas at HLTH. Her company Dyania Health is one of the most exciting AI companies in health-tech today, and they just announced $10 million in Series A funding. Watch on YouTube. Eirini Schlosser discusses how Dyania Health uses AI and large language models to revolutionize patient care, specifically for cancer and heart failure patients. It's really one of the most awesomely beneficial uses for AI that I've seen yet, and it's a product we should all be excited about.

Denver Nuggets Rookie Spencer Jones chats about his experience with Jokic, Westbrook, and how he uses his NBA influence to advise health tech startups, many of which are aimed at helping his on-court performance. The views and opinions expressed in this video are solely those of the individuals featured and do not necessarily represent the views or opinions of Athletes & Assets. We do not accept liability for any advice given in this video, and viewers are encouraged to seek professional guidance before making any business decisions. Additionally, the participation of athletes in this video does not imply endorsement or sponsorship by their respective employers.

DOJ filed criminal charges against 193 defendants, including 76 medical professionals for telemedicine violation. This alarming crackdown reveals the vulnerabilities within telemedicine, as illegal kickbacks and brief consultations have led to significant fraud, particularly in Medicare claims.Among the troubling cases highlighted, one psychiatrist was accused of billing for telehealth visits lasting only 10 to 30 seconds, falsely classified as legitimate patient consultations. The DOJ's focus on these practices serves as a critical reminder that telehealth providers must adhere to stringent federal and state regulations to avoid legal repercussions, including criminal charges and loss of medical licenses.Healthcare practitioners are urged to ensure their telehealth practices are not only clinically sound but also compliant with legal standards. For those in the telehealth space, seeking legal guidance is paramount to safeguarding their practices and upholding patient care standards. The Kulkarni Law Firm is available to assist healthcare professionals in navigating these challenges and avoiding potential fraud schemes.As the telemedicine landscape evolves, it's vital to consider whether the convenience of remote consultations outweighs the increased scrutiny and risks associated with them. Join the conversation by sharing your thoughts on the future of telehealth in the comments below.Support the show

In today's episode, Scott Becker covers key stock movements, from Oscar Health and Ardant Health facing significant drops, to Coinbase's impressive surge and Tesla's continued strength. He highlights the volatility in various sectors, from healthcare to tech, and emphasizes the importance of a steady allocation in these unpredictable times.

In this episode of Medsider Radio, we sat down with returning guest, Don Crawford, CEO of CorVista Health. CorVista is developing a non-invasive medical device that uses advanced machine-learned algorithms to detect heart conditions, right in a doctor's office.Don's career began at Medtronic, followed by progressively senior sales and marketing roles at Guidant Corporation, Ventritex, and Intermedics, including overseeing a $100 million international cardiovascular business. Before CorVista, he led Sapheon, a venous device company, to a $238 million acquisition by Covidien. In this interview, Don talks about the need for focus in startups, the importance of precise data collection, and the value of transparency and respect within teams. He also shares his approach to hiring and building a top-notch group of people.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Don Crawford.

In today's episode, Scott Becker covers key stock movements, from Oscar Health and Ardant Health facing significant drops, to Coinbase's impressive surge and Tesla's continued strength. He highlights the volatility in various sectors, from healthcare to tech, and emphasizes the importance of a steady allocation in these unpredictable times.

Scaling the Unscalable: How One Device is Tackling Healthcare's Biggest ChallengesCan a single device predict health events a week in advance with 92% accuracy? In our latest podcast episode, we explore how creative health monitoring tools are reshaping chronic care management and addressing some of healthcare's most pressing issues.

In this new episode of ‘Narratives of Purpose', Mariatheresa Samson Kadushi and Shamala Hinrichsen join host Claire Murigande to discuss the innovative app "SheHer" designed to advance women's health by providing accessible healthcare information and fostering a supportive community. Both Shamala and Mariatheresa emphasise the importance of centring women's dignity in healthcare, highlighting the disparities that still exist in the industry. They share their personal journeys into the health tech space and the biases female founders encounter when seeking funding, illustrating the broader societal challenges that persist even in progressive sectors like health tech. By collaborating and leveraging their diverse backgrounds, Mariatheresa and Shamala, together with their three co-founders, aim to revolutionise women's health and encourage others to join in this vital work.This episode encourages a rethinking of how healthcare solutions are developed and delivered, advocating for a model that prioritises the voices and needs of women, particularly those from marginalised communities.Be sure to visit our podcast website for the full episode transcript. RELEVANT LINKS:More about the SheHer app at this websiteFollow the SheHer app: Instagram Connect with Mariatheresa Samson Kadushi: LINKEDIN Connect with Shamala Hinrichsen: LINKEDIN Follow our host: WEBSITE | LINKEDINFollow us: LinkedIn | Instagram Connect with us: narrativespodcast@gmail.com | subscribe to our news Tell us what you think: write a review This second part of our Women's Health series is supported by We Shape Tech.CHAPTERS:00:06 - Welcome to Narratives of Purpose00:55 - Meet Shamala Hinrichsen and Mariatheresa Samson Kadushi01:33 - The Mission of SheHer App03:48 - Shamala's Journey into Health Tech03:00 - Mariatheresa's Background in Tech06:30 - Building a Diverse Team for Women's Health11:18 - The Importance of Women's Stories21:32 - Challenges Faced by Female Founders35:48 - Calls to Action for Listeners38:23 - Closing Remarks and Future Outlook

Thousands of area high school students will meet and speak with industry leaders in December. Heather Hovland from Job Service of North Dakota gives KFGO listeners all the details on the expo and how you can include your business or trade as well!See omnystudio.com/listener for privacy information.

Keep up with healthcare news in under an hour with our monthly Digital Health Download! We can't believe it's already November. In this episode, we cover the biggest headlines of October:

Doctors are not okay. Nearly half of physicians in the United States experienced burnout in 2023, leading to absenteeism, reduced productivity, turnover, and many leaving the profession altogether. In this episode, we discuss the clinician burnout and mental health crises with two expert guests: Dr. Jessie Gold, the first chief wellness officer for the University of Tennessee System and author of "How Do You Feel? One Doctor's Search for Humanity in Medicine," and Dr. Aparna Atluru, co-founder and chief medical officer of Marvin, a company that provides specialized mental health care for healthcare workers.We cover:

https://learntruehealth.com/vibe coupon code LTH - LearnTrueHealth.com/vibe